Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19.

Arnaldos-Carrillo M. et al, (2023), Med Clin (Barc), 161, 185 - 191

Vitamin D Deficiency (VDD) and Susceptibility towards Severe Dengue Fever-A Prospective Cross-Sectional Study of Hospitalized Dengue Fever Patients from Lahore, Pakistan.

Iqtadar S. et al, (2023), Trop Med Infect Dis, 8

Tocilizumab therapy for severely-ill COVID-19 pneumonia patients: a single-centre retrospective study.

Iqtadar S. et al, (2022), J Physiol Pharmacol, 73

Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.

Haroon MZ. et al, (2022), J Physiol Pharmacol, 73

Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes - a case series from Lahore, Pakistan.

Iqtadar S. et al, (2022), Ther Adv Infect Dis, 9

Virus-induced senescence is a driver and therapeutic target in COVID-19.

Lee S. et al, (2021), Nature, 599, 283 - 289

Include forthcoming?